Pulmonary Hypertension News

January 15, 2021January 15, 2021

HealthWell Foundation Offering Grants to Offset Cost of PH Treatments

The HealthWell Foundation has opened a fund to help people with pulmonary hypertension (PH) in the U.S. who are on Medicare with covering their healthcare costs. The fund will offer awards ... Read more

January 13, 2021January 13, 2021

Prolargin Shows Early Promise as PAH Biomarker

Pulmonary Hypertension News

The prolargin protein may serve as a biomarker for pulmonary arterial hypertension (PAH), allowing for earlier diagnosis and differentiating among different types of pulmonary hypertension (PH), according to a recent ... Read more

January 12, 2021January 13, 2021

NORD Seeks Speakers for 2021 Virtual ‘Living Rare, Living Stronger’ Forum

Pulmonary Hypertension News

The National Organization for Rare Disorders (NORD) is seeking individuals willing to share real-life experiences with rare diseases to speak at its upcoming virtual Living Rare, Living Stronger NORD Patient ... Read more

January 11, 2021January 11, 2021

Novel Gene Implicated in PH Development in Preclinical Study

Pulmonary Hypertension News

A gene called DNMT3B was found for the first time to be a mediator of blood vessel wall growth, and has been implicated in the development of pulmonary hypertension (PH) in ... Read more

January 8, 2021January 8, 2021

High Creatinine, NT-proBNP Levels Found to Be Mortality Risk Factors

Pulmonary Hypertension News

Elevated blood levels of the kidney disease biomarker creatinine and the heart failure biomarker NT-proBNP were found to be independent predictors of mortality for older people with pulmonary arterial hypertension ... Read more

January 6, 2021January 6, 2021

FDA Priority Review Likely for Tyvaso DPI, Inhaled Treprostinil for PAH

Pulmonary Hypertension News

United Therapeutics is planning to ask the U.S. Food and Drug Administration (FDA) for an accelerated review of Tyvaso DPI, an investigational therapy-inhaler device treatment for two forms of pulmonary hypertension, in ... Read more

January 4, 2021January 4, 2021

Atrial Flow Regulator Receives FDA’s Breakthrough Device Designation

Pulmonary Hypertension News

Occlutech’s atrial flow regulator (AFR) — a cardiac implant — received breakthrough device designation from the U.S. Food and Drug Administration for the treatment of pulmonary arterial hypertension (PAH). Breakthrough ... Read more

December 30, 2020December 30, 2020

Phase 2 Trial to Assess Revatio in Premature Infants With BPD at Risk of PH

Pulmonary Hypertension News

Researchers have designed a Phase 2 clinical trial to test the safety and preliminary effectiveness of Revatio (sildenafil) in preventing pulmonary hypertension (PH) in premature infants with severe bronchopulmonary dysplasia ... Read more

December 21, 2020December 21, 2020

PHA Names New President and CEO, Matt Granato

Pulmonary Hypertension News

Matt J. Granato is the newly named president and CEO of the Pulmonary Hypertension Association (PHA), the nonprofit group announced. Granato, who has more than 20 years of experience working ... Read more

December 18, 2020December 18, 2020

Sotatercept Receives Orphan Drug Designation in Europe

Pulmonary Hypertension News

The European Commission has granted orphan drug designation to sotatercept for the treatment of people with pulmonary arterial hypertension (PAH). This designation is given to medications with the potential to ... Read more

December 16, 2020December 16, 2020

Bosentan May Lower Risk of PH in Certain Scleroderma Patients

Pulmonary Hypertension News

Treatment with bosentan may lower the risk of developing pulmonary hypertension (PH) and help stabilize lung function in scleroderma patients with digital ulcers, a study suggests. Patients who never had ... Read more

December 14, 2020December 14, 2020

Lower Quality of Life in PH Patients Linked to Higher Caregiver Burden in Study

Pulmonary Hypertension News

Lower quality of life in patients with pulmonary hypertension (PH) was found to be associated with higher burden experienced by their caregivers, according to a study conducted in Turkey. The ... Read more

December 11, 2020December 11, 2020

ILD Associated with PH Linked to Worse Survival Outcomes in Study

Pulmonary Hypertension News

People with both pulmonary hypertension (PH) and interstitial lung disease (ILD) have worse survival outcomes than ILD patients who don’t have PH, a study has found. Lung function and blood ... Read more

December 9, 2020December 9, 2020

FLNA Gene Mutations Linked in Case Reports to Progressive PAH in Children

Pulmonary Hypertension News

Researchers have identified a new mutation in the FLNA gene that was linked with pulmonary arterial hypertension (PAH) and congenital heart defects in a two-year-old girl. This case, along with more ... Read more